ILFS1 is clinically characterized by recurrent liver dysfunction, intrauterine growth retardation, failure to thrive, neurodevelopmental delay, encephalopathy, microcytic anemia, hypoalbuminemia, coagulation disorders, and muscular hypotonia [3]. This evidence concerns the gene LARS1 and Decreased liver function.